A rare case of vernakalant-induced 1:1 atrial flutter during chemical cardioversion of atrial fibrillation requiring emergency direct current cardioversion. (2nd June 2021)

• Record Type: Journal Article
• Authors: Stoneman, Paul; Adams, Joseph; Colbert, Fiona; Sheahan, Richard
• Is Part Of: British journal of cardiac nursing. Volume 16:Number 6(2021)
• Page Start: 1
• Page End: 4
• Publication Date: 2021-06-02
• Subjects: Advanced nurse practitioner -- Advanced practice -- Atrial fibrillation -- Atrial flutter -- Cardioversion; Heart -- Diseases -- Nursing -- Great Britain -- Periodicals; 616.10231
• DOI: 10.12968/bjca.2021.0002
• Languages: English
• ISSNs: 1749-6403

Abstract

Abstract : Vernakalant is an atrial-selective, multi-channel anti-arrhythmic that offers a safe alternative to traditional approaches to chemical cardioversion of recent-onset, non-valvular atrial fibrillation. This case report describes a very rare occurrence of unstable accelerated 1:1 atrial flutter during an attempted cardioversion of non-valvular atrial fibrillation using vernakalant hydrochloride that required emergent direct current cardioversion. This case report highlights the need for clinicians to remain vigilant and be prepared to treat rare consequences of vernakalant administration.